Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging studyBMJ Publishing Group Ltd and European League Against Rheumatism
12 October 2021
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunityDaniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer, Stefan Winkler, Stephan Blüml, Karin Stiasny, Judith H Aberle, Josef S SmolenSee the full list of authors
20 July 2021
Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon diseaseEmma Garcia-Melchor, Giacomo Cafaro, Lucy MacDonald, Lindsay A N Crowe, Shatakshi Sood, Michael McLean, Umberto G Fazzi, Iain B McInnes, Moeed Akbar, Neal L Millar
10 March 2021
Retraction: Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritisBMJ Publishing Group Ltd and European League Against Rheumatism
6 July 2021
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle, Pedro M Machado
15 February 2021
Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment responseSvetlana Cherlin, Myles J Lewis, Darren Plant, Nisha Nair, Katriona Goldmann, Evan Tzanis, Michael R Barnes, Paul McKeigue, Jennifer H Barrett, Costantino Pitzalis, Anne Barton, MATURA Consortium, Heather J Cordell
30 July 2020
Correction: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 updateBMJ Publishing Group Ltd and European League Against Rheumatism
14 September 2020
Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging studyBMJ Publishing Group Ltd and European League Against Rheumatism
14 August 2020
Correction: Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysisBMJ Publishing Group Ltd and European League Against Rheumatism
14 August 2020
Correction: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reductionBMJ Publishing Group Ltd and European League Against Rheumatism
14 August 2020
